This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Juvenile xanthogranuloma

Authoring team

  • benign histiocytic tumours
  • solitary or multiple
  • often present at birth or in early infancy
  • clinical features:
    • firm, small, red-brown nodules
    • common sites - face, neck, scalp
  • management:
    • referral for specialist review is recommended (2,3)
      • there is an association between juvenile xanthogranuloma, neurofibromatosis and juvenile chronic myelogenous leukaemia
        • Zvulunov et al (3) found evidence that a concomitant finding of and juvenile xanthogranuloma in children with neurofibromatosis represents a true association, rather than a coincidence. A finding of juvenile xanthogranuloma in an infant with neurofibromatosis should alert a physician to a possible development of juvenile chronic myelogenous leukaemia
    • in general, no treatment of the skin lesions is required - there tends to be a spontaneous regression of lesions
    • ophthalmology examination is recommended because disseminated lesions can be associated with ophthalmic involvement

Reference:

  1. Dermatology in Practice (2001), 9 (4), 20.
  2. Jang KA et al.Juvenile chronic myelogenous leukemia, neurofibromatosis 1, and xanthoma. J Dermatol. 1999 Jan;26(1):33-5.
  3. Zvulunov A, Barak Y, Metzker A.Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis Arch Dermatol. 1995 Aug;131(8):904-8.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.